 SOUTH SAN FRANCISCO, Calif., Dec. 19, 2022 GLOBE NEWSWIRE -- Senti Biosciences, Inc. Nasdaq: SNTI Senti Bio, a biotechnology company innovating next-generation cell and gene therapies using its proprietary gene circuit platform, today announced that Tim Lu, MD, PhD, Co-founder and Chief Executive Officer, will present a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 5:15 p.m. PT. 